All blog items

Requesting Access in OnCore

The OnCore Service Team has noticed that there continues to be confusion regarding requesting OnCore Access.  To assist the Research Community in requesting OnCore Access, the correct process for requesting access has been outlined below along with notes where requestors often make mistakes in the access request process.  

Funding Opportunities from CTSI

CTSI Population Health Improvement Co-Development Awards: LOI Deadline January 24, 2019 Encourages and facilitates new investigative community-academic partnerships designed to improve community health and may also include health research that advances the science of stakeholder and community-engaged research.

Clinical Research Update - January 2019

Research Community News DOCR News Did You Know? Training Opportunities Clinical Research Employee Highlights Partner Resources Research Community News  

2018: The Year in Discovery at Duke

  School of Medicine stories are among Duke Today's best reads in Duke scholarship of 2018. Scientists Find Stomach Cells in Lung Cancer A surprising discovery of unexpected cells in a cancer tumor underscores the amazing resilience and plasticity of cancer cells. Read More.

Inaugural Cohort in National Clinician Scholars Program Named at Duke, VA

Researchers Represent Schools of Nursing, Medicine and Durham VA Health Care System Three physicians and two post-doctoral nurses will comprise the inaugural cohort for Duke’s National Clinician Scholars Program (NCSP). The cohort represents the first group of interdisciplinary medical researchers selected for the newly established Duke NCSP site. 

Kornbluth and Sullenger Named to National Academy of Inventors

Duke University Provost Sally Kornbluth and Bruce Sullenger, PhD, have been elected Fellows of the National Academy of Inventors (NAI) class of 2018. They are among 148 new fellows this year and join 11 other Duke faculty who have been so recognized by the 7-year-old organization.

Roadmap Reveals Shortcut to Recreate Key HIV Antibody for Vaccines

HIV evades the body’s immune defenses through a multitude of mutations, and antibodies produced by the host’s immune system to fight HIV also follow convoluted evolutionary pathways that have been challenging to track.  This complexity has made it difficult for researchers to develop a preventive HIV vaccine that elicits effective antibodies similar to those that evolve in some people living with HIV. This is a task akin to retracing a traveler’s exact journey knowing only the destination, with few clues to the myriad possible origins and routes.